Urgent call to action! We have 30 days to convince the FDA to reject the Pfizer mRNA shot in kids!!

We have 30 days to convince the FDA to reject the Pfizer mRNA shot in kids under 5.

In the war against Pharma fascism, this is our D Day.

By Toby Rogers (original post on substack)

On February 10, we achieved a remarkable victory — Pfizer was forced to withdraw its Emergency Use Authorization application to inject kids 6 months to four years old because the data was so terrible. But it was a temporary reprieve. Even though Pfizer’s clinical trials of the genetically modified mRNA shot have already failed twice in this age group, Pfizer is planning to submit another application for Emergency Use Authorization in early April — just under 30 days from now.

This is one of the last battles in this phase of the war. There are 18 million children under five who are potentially impacted by this decision. But Pfizer’s real goal is to achieve permanent liability protection. Currently, Pfizer shots are authorized for emergency use and given liability protection under the PREP Act. But emergency use authorization expires, usually after a year, so Pfizer has to apply for full approval — which is not difficult because they control the FDA. Once the shot has full approval, Pfizer loses the liability protection offered by the PREP Act and is potentially exposed to billions of dollars of injury claims for their faulty product. However, if Pfizer can get the mRNA shot added to the childhood vaccine schedule, then it will enjoy permanent liability protection under the 1986 National Childhood Vaccine Injury Act. So that’s what this fight is all about. RFK Jr. explains the whole thing in 2 minutes here:

https://mobile.twitter.com/FatEmperor/status/1475930299674636288

We absolutely must find a way to defeat the upcoming Pfizer EUA application in kids 6 months to 4 years old.

So here’s the plan. I and a group of allies are going to put out a call to action once a week from now until the FDA meets to consider this application. Each week we are going to focus on a different pillar of the corrupt system. We need you to dedicate one hour a week to sending out 25 emails, making 25 calls, send 25 letters, or sending 25 faxes. It seems like a big ask until you realize that the alternative is to live under Pharma tyranny for the rest of our lives. The momentum is on our side, the data is on our side, every day more politicians come over to our side, we are the majority, this is our moment, we must embrace our responsibility to stop this insanity.

Many of you have participated in my calls to action before (THANK YOU!!!) What’s new or different about this call to action? I’ve got much better talking points. There is a new FDA Commissioner, Robert Califf, who we need to educate about these matters. We are reaching deeper inside the bureaucracy to educate some of the staffers who write the reports that are part of the evaluation process. And there are several new members of the Vaccines and Related Biological Products Advisory Committee who need to hear from us as well.

Talking Points

Feel free to compose your own message or share your story with the federal officials listed below. Alternatively you can copy and paste these talking points into your message.

Subject line: please REJECT the Pfizer EUA application to inject mRNA into kids 6 months to 4 years old when it returns in April

1. There is no Covid emergency for children under five years old.

Children have a 99.995% recovery rate and a body of medical literature indicates that almost zero healthy children under five years old have died from Covid.

• A large study conducted in Germany showed zero deaths for children under 5 and a case fatality rate of three out of a million in children without comorbidities.

•A Johns Hopkins study monitoring 48,000 children diagnosed with Covid showed a zero mortality rate in children under 18 without comorbidities.

•A study in Nature demonstrated that children under 18 with no comorbidities have virtually no risk of death.

2. The Pfizer mRNA shot does not work very well in kids.

The Pfizer clinical trial in kids 6 months to four years old failed in December 2021 and failed again in February 2022. Adding a third dose is not going to solve the underlying problems with this vaccine in this age group.

The FDA and CDC claimed that the Pfizer shot was 90% effective in kids 5 to 11. Recently released data show that it was only 12% effective against the Omicron variant. So all of the FDA and CDC risk benefit calculations were wrong.

By contrast, there are more than 1,500 studies in connection with about twenty off-the-shelf medicines that are safe and effective. Prophylaxis and early treatment with these medicines offer a better alternative than risky mRNA shots.

3. The harms from the Pfizer mRNA shot in children are catastrophic.

There are now 4,376 VAERS reports of adverse events in children following Covid shots. These reports likely understate harms by a factor of 41 to 100.

There are troubling reports of fatalities in children following Covid shots: https://openvaers.com/covid-data/child-reports/1975356 https://openvaers.com/covid-data/child-reports/2109625 https://openvaers.com/covid-data/child-reports/2152560 https://www.icandecide.org/ican_press/report-of-toddlers-death-disappears-from-vaers-and-cdc-has-no-records-as-to-why/

Everyone knows that FDA approval = CDC adding it to the childhood schedule = liability protection forever = mandates = widespread iatrogenic injury.

You have a professional and moral obligation to reject Pfizer’s EUA application for kids 6 months to 4 years old.

People to contact:

Please reach out and find a way to awaken the moral core of these 24 people:

Rochelle Walensky Director, Centers for Disease Control and Prevention Roybal Building 21, Rm 12000 1600 Clifton Rd Atlanta, GA 30333 phone: (404) 639-7000 Aux7@cdc.gov https://twitter.com/CDCDirector

Xavier Becerra Secretary, Health & Human Services 200 Independence Avenue S.W. Washington, D.C. 20201 c/o Sean McCluskie sean.mccluskie@hhs.gov https://twitter.com/XavierBecerra

Robert Califf FDA Commissioner FDA Mail stop: HF-1 Parklawn Building 12420 Parklawn Drive Rockville, Maryland, 20852 phone: (301) 796-5400 fax: (301) 847-8752 commissioner@fda.hhs.gov https://twitter.com/DrCaliff_FDA

Peter Marks Director, Center for Biologics Evaluation and Research FDA, Mail stop: HFM-2 10903 New Hampshire Ave., WO71-7232 Silver Spring MD 20993-0002 phone: (240) 402-8116 fax: (301) 595-1310 Peter.Marks@fda.hhs.gov

Hong Yang Biologist, FDA/CBER/OBE Building WO71, Room 5338 Mail stop: HFM-210 Silver Spring MD 20993-0002 phone: (240) 402-8836 fax: (301) 595-1240 Hong.Yang@fda.hhs.gov

Richard Forshee Associate Director, FDA/CBER/OBE Building, WO71, Room 5342 Silver Spring MD 20993-0002 phone: (240) 402-8631 fax: (301) 595-1240 Richard.Forshee@fda.hhs.gov

Hui-Lee Wong Associate Director for Innovation and Development, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research White Oak Building 71, Room 5222 Silver Spring MD 20993-0002 phone: (240) 402-0473 Huilee.Wong@fda.hhs.gov

Leslie Ball Office of Vaccines Research and Review Division of Vaccines and Related Products Applications, Center for Biologics Evaluation and Research Building WO22, Room 6156 Silver Spring MD 20993-0002 phone: (301) 796-3399 Leslie.Ball@fda.hhs.gov

Doran L. Fink Deputy Director – Clinical, Division of Vaccines and Related Products Applications Office of Vaccines Research and Review, CBER Mail stop HFM-475 Building WO71, Room 3314 Silver Spring MD 20993-0002 phone: (301) 796-1159 Doran.Fink@fda.hhs.gov

VRBPAC Members:

Hana El Sahly, M.D., Chair VRBPAC Associate Professor Department of Molecular Virology and Microbiology Department of Medicine Section of Infectious Diseases Baylor College of Medicine Houston, TX 77030 713-798-2058 hanae@bcm.edu

Paula Annunziato, M.D. Vice President and Therapeutic Area Head Vaccines Clinical Research Merck North Wales, PA 19454 paula.annunziato@merck.com

Adam C. Berger, Ph.D. Director, Division of Clinical and Healthcare Research Policy Office of Science Policy Office of the Director National Instituters of Health 6705 Rockledge Drive, Suite 630 Bethesda, MD 20892 (301) 827-9676 adam.berger@nih.gov

Henry H. Bernstein, D.O. Professor of Pediatrics Zucker School of Medicine at Hofstra/Northwell Department of Pediatrics Cohen Children’s Medical Center New Hyde Park, NY 11042 phone: (516) 838-6415 (office) fax: (516) 465-5399 hbernstein@northwell.edu

Captain Amanda Cohn Chief Medical Officer National Center for Immunizations and Respiratory Diseases Centers for Disease Control and Prevention 1600 Clifton Rd Atlanta, GA 30333 MS C-09 phone: (404) 639-6039 fax: (404) 315-4679 acohn@cdc.gov anc0@cdc.gov

Holly Janes, Ph.D. Fred Hutchinson Cancer Research Center • Vaccine and Infectious Disease Division 1100 Fairview Avenue North, M2-C200 P.O. Box 19024 Seattle, Washington 98109 U.S.A. phone: (206) 667.6353 hjanes@fredhutch.org

Hayley Gans, M.D. Professor of Pediatrics Department of Pediatrics Stanford University Medical Center Stanford, CA 94305 phone: (650) 723-5682 fax: (650) 725-8040 hgans@stanford.edu

David Kim, M.D. CAPT, U.S. Public Health Services Office of Infectious Disease and HIV/AIDS Policy Office of the Assistant Secretary for Health U.S. Department of Health and Human Services 330 C Street SW, Suite L600 Washington, DC 20024 phone: (202) 795-7636 david.kim@hhs.gov

Arnold Monto, M.D. Professor Emeritus Department of Epidemiology University of Michigan School of Public Health Ann Arbor, MI 48109 phone: (734) 764-5453 fax: (734) 764-3192 asmonto@umich.edu

Paul Offit, M.D. Professor of Pediatrics Division of Infectious Diseases Abramson Research Building The Children’s Hospital of Philadelphia Philadelphia, PA 19104 phone: (215) 590-2020 offit@chop.edu https://twitter.com/DrPaulOffit

Steven Pergam, M.D. Medical Director Infection Prevention Seattle Cancer Care Alliance Seattle, WA 98109 phone: (206) 667-7126 spergam@fredhutch.org https://twitter.com/PergamIC

Jay Portnoy, M.D. Director, Division of Allergy, Asthma & Immunology Children’s Mercy Hospitals & Clinics 2401 Gillham Road Kansas City, MO 64108 phone: (816) 960-8885 fax: (816) 960-8888 Jportnoy@cmh.edu

Eric Rubin, M.D., Ph.D. Editor-in-Chief New England Journal of Medicine Adjunct Professor Harvard TH Chan School of Public Health 665 Huntington Ave Building 1, Room 811 Boston, MA 02115 phone: (617) 432-3335 erubin@hsph.harvard.edu erubin@nejm.org

Andrea Shane, M.D. Professor of Pediatrics Emory University School of Medicine 2015 Uppergate Drive NE, Rm. 504A Atlanta, GA 30322 phone: (404) 727-9880 (direct) (404) 727-5642 (main) fax: (404) 727-8249 ashane@emory.edu

Geeta K. Swamy, M.D. Senior Associate Dean Vice Chair for Research & Faculty Development Associate Professor, Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine Duke University Box 3967 Med Ctr, Durham, NC 27710 phone: (919) 681-5220 swamy002@mc.duke.edu

Please be respectful and courteous. The fate of our nation is at stake. Let’s GOOOOOOOOO! 🙌

Blessings to the warriors! 🙌

Prayers for everyone fighting to restore sanity to our troubled land. 🙏

Please share this call to action on social media and with your friends and family.

In the comments, please let me know how you go with contacting these people, let me know if you get any replies, and please alert me if you get any bounces or notice any corrections.

Also, please bookmark this article and check back frequently for any updates.